Akshaya Keerti: The potential of Datopotamab Deruxtecan in lung cancer

Akshaya Keerti shared a post on LinkedIn:

”Excited to share my latest blog on the groundbreaking potential of Datopotamab Deruxtecan in transforming lung cancer treatment! Discover how this innovative drug is making strides in improving survival rates for NSCLC patients.”

Read further.
Source: Akshaya Keerti/LinkedIn

Akshaya Keerti is the International Council Deputy Director at the Federation of Medical Students Association (FMSA) and a Professional Member of Erevnites. He also serves as a Medical Officer at Meherbai Tata Memorial Cancer Hospital and is an Academic Lecturer with Project IMG.